Sato S - Search Results

1

Fujimoto M, Sato S. Fujimoto M, et al. Among authors: sato s. Curr Opin Rheumatol. 2005 Nov;17(6):746-51. doi: 10.1097/01.bor.0000179945.73518.28. Curr Opin Rheumatol. 2005. PMID: 16224253 Review.

2

Systemic sclerosis revealing T-cell lymphoma.

Hasegawa M, Sato S, Sakai H, Ohashi T, Takehara K. Hasegawa M, et al. Among authors: sato s. Dermatology. 1999;198(1):75-8. doi: 10.1159/000018070. Dermatology. 1999. PMID: 10026408

3

Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.

Hasegawa M, Sato S, Takehara K. Hasegawa M, et al. Among authors: sato s. Clin Exp Immunol. 1999 Jul;117(1):159-65. doi: 10.1046/j.1365-2249.1999.00929.x. Clin Exp Immunol. 1999. PMID: 10403930 Free PMC article.

4

Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.

Hasegawa M, Sato S, Ihn H, Takehara K. Hasegawa M, et al. Among authors: sato s. Rheumatology (Oxford). 1999 Jul;38(7):612-7. doi: 10.1093/rheumatology/38.7.612. Rheumatology (Oxford). 1999. PMID: 10461473

5

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.

Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Kaburagi Y, Nagaoka T, Takehara K, Tedder TF, Sato S. Saito E, et al. Among authors: sato s. J Clin Invest. 2002 Jun;109(11):1453-62. doi: 10.1172/JCI15078. J Clin Invest. 2002. PMID: 12045259 Free PMC article.

6

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. J Invest Dermatol. 2003 Apr;120(4):542-7. doi: 10.1046/j.1523-1747.2003.12097.x. J Invest Dermatol. 2003. PMID: 12648215 Free article.

7

CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

Yazawa N, Fujimoto M, Sato S, Miyake K, Asano N, Nagai Y, Takeuchi O, Takeda K, Okochi H, Akira S, Tedder TF, Tamaki K. Yazawa N, et al. Among authors: sato s. Blood. 2003 Aug 15;102(4):1374-80. doi: 10.1182/blood-2002-11-3573. Epub 2003 Apr 24. Blood. 2003. PMID: 12714520 Free article.

8

Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.

Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y, Hatamochi A, Kondo H, Takehara K. Kuwana M, et al. Among authors: sato s. J Rheumatol. 2003 Jun;30(6):1253-8. J Rheumatol. 2003. PMID: 12784399

9

Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S. Furuse S, et al. Among authors: sato s. J Rheumatol. 2003 Jul;30(7):1524-8. J Rheumatol. 2003. PMID: 12858452

10

Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.

Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Hasegawa M, et al. Among authors: sato s. Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783. Dermatology. 2003. PMID: 12920362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,182 results

Search Page

Filters